Comparison
NMN vs Pterostilbene
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Pterostilbene
Methylated analog of resveratrol with much higher bioavailability. Found in blueberries.
| Field | NMN | Pterostilbene |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 50–250mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 280 |
The comparison in plain English
Auto-generated from dataNMN and Pterostilbene are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Pterostilbene Methylated analog of resveratrol with much higher bioavailability.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Pterostilbene (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Pterostilbene if
Pterostilbene is the better fit when your goal aligns with its mechanism (Pterostilbene is structurally similar to resveratrol but with two methyl groups attached, increasing lipophilicity and substantially improving blood-brain-barrier penetration (4x oral bioavailability and a longer half-life vs resveratrol)) and the dose range (50–250mg) suits your protocol. Half-life is —h.